Report cover image

Infectious Diseases In-Vitro Diagnostics Market Intelligence Report - Global Forecast 2023-2030

Published Feb 01, 2023
Length 186 Pages
SKU # TMI17687693

Description

Infectious Diseases In-Vitro Diagnostics Market Intelligence Report - Global Forecast 2023-2030

The Global Infectious Diseases In-Vitro Diagnostics Market is projected to reach USD 79.95 billion by 2030 from USD 45.85 billion in 2022, at a CAGR 7.19% during the forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions.

In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Infectious Diseases In-Vitro Diagnostics Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the Global Infectious Diseases In-Vitro Diagnostics Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Product:

  • Instruments
  • Reagents
  • Software

Technology:

  • Immunochemistry
  • Microbiology
  • Molecular Diagnostics

Indication:

  • Candidiasis
  • Chlamydia
  • Clostridium difficile
  • CRE
  • Gastroenteritis
  • Gonorrhea
  • Hepatitis
  • HIV
  • HPV
  • MRSA
  • Respiratory Virus
  • Streptococcus
  • TB and Drug-resistant TB
  • VRE

End-user:

  • Central Laboratories
  • Point of Care
  • Rapid Test Kit

Region:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year

Table of Contents

186 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Market Overview
4. Americas Infectious Diseases In-Vitro Diagnostics Market
4.1. Introduction
4.2. Argentina
4.3. Brazil
4.4. Canada
4.5. Mexico
4.6. United States
5. Asia-Pacific Infectious Diseases In-Vitro Diagnostics Market
5.1. Introduction
5.2. Australia
5.3. China
5.4. India
5.5. Indonesia
5.6. Japan
5.7. Malaysia
5.8. Philippines
5.9. Singapore
5.10. South Korea
5.11. Taiwan
5.12. Thailand
5.13. Vietnam
6. Europe, Middle East & Africa Infectious Diseases In-Vitro Diagnostics Market
6.1. Introduction
6.2. Denmark
6.3. Egypt
6.4. Finland
6.5. France
6.6. Germany
6.7. Israel
6.8. Italy
6.9. Netherlands
6.10. Nigeria
6.11. Norway
6.12. Poland
6.13. Qatar
6.14. Russia
6.15. Saudi Arabia
6.16. South Africa
6.17. Spain
6.18. Sweden
6.19. Switzerland
6.20. Turkey
6.21. United Arab Emirates
6.22. United Kingdom
7. Appendix
7.1. Discussion Guide
7.2. License & Pricing
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.